Protalix BioTherapeutics
PLX
#8601
Rank
ยฃ0.18 B
Marketcap
ยฃ2.22
Share price
-5.23%
Change (1 day)
65.87%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): ยฃ0.23

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.24. In 2025 the company made an earnings per share (EPS) of -ยฃ0.06115 a decrease over its 2024 EPS that were of ยฃ0.03058.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ0.23-482.19%
2025-ยฃ0.06115-300%
2024ยฃ0.03058-66.67%
2023ยฃ0.09173-138.71%
2022-ยฃ0.24-50%
2021-ยฃ0.47181.82%
2020-ยฃ0.17-82.11%
2019-ยฃ0.94-31.67%
2018-ยฃ1.38-72.31%
2017-ยฃ4.97124.14%
2016-ยฃ2.22-147.54%
2015ยฃ4.66-290.62%
2014-ยฃ2.456.67%
2013-ยฃ2.29130.77%
2012-ยฃ0.99-69.77%
2011-ยฃ3.2919.44%
2010-ยฃ2.75-12.2%
2009-ยฃ3.1336.67%
2008-ยฃ2.29-37.5%
2007-ยฃ3.6750%
2006-ยฃ2.453.23%
2005-ยฃ2.37138.46%
2004-ยฃ0.99-74%
2003-ยฃ3.82-0%
2002-ยฃ3.82-50%
2001-ยฃ7.64233.33%
2000-ยฃ2.29-84.21%
1999-ยฃ14.52-24%
1998-ยฃ19.11-600%
1997ยฃ3.82-16.67%
1996ยฃ4.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54 129.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.33 2,148.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08409-135.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.34 45.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel